Research Article
Predictors of Outcome and Severity in Adult Filipino Patients with Febrile Neutropenia
Table 3
Microbiologic profiles of febrile neutropenia cases.
| Microbiologic parameter | Outcome frequency (%) | Complicated group | Noncomplicated group |
| Infection type | | | MDI | 20 (34.5) | 12 (21.1) | CDI | 36 (62.1) | 43 (75.4) | FUO | 2 (3.4) | 2 (3.5) | Site of infection | | | Oral cavity | 2 (3.4) | 15 (26.3) | Respiratory tract | 33 (56.9) | 25 (43.9) | GI tract/intra-abdominal | 4 (6.9) | 2 (3.5) | Genitourinary tract | 13 (22.4) | 6 (10.5) | Skin and soft tissue | 4 (6.9) | 6 (10.5) | Unknown | 1 (1.7) | 0 | Others | 1 (1.7) | 3 (5.6) | Bacteremia | | | Yes | 7 (12.1) | 8 (14) | No | 51 (87.9) | 49 (86) | Isolated organism | | | Gram positive bacteria, non-MDRO | 3 (12) | 0 | Gram positive bacteria, MDRO | 3 (12) | 1 (6.7) | Gram negative bacteria, non-MDRO | 8 (32) | 4 (26.7) | Gram negative bacteria, MDRO | 7 (28) | 4 (26.7) | Fungus | 4 (16) | 4 (26.7) | TB | 0 | 2 (13.3) | Antibiotic use | | | Complete | 21 (36.2) | 39 (68.4) | Incomplete | 37 (64.8) | 18 (31.2) |
|
|
MDRO: multi-drug-resistant organism.
|